Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan
Clinical trial NCT06892249 · COMPLETED
Trial details
- NCT number
- NCT06892249
- Sponsor
- Fresenius Kabi Taiwan Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-04
- Primary completion
- 2026-04-21
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.